Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels

[1]  Melissa C Skala,et al.  Longitudinal optical imaging of tumor metabolism and hemodynamics. , 2010, Journal of biomedical optics.

[2]  M. Dewhirst.  Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress , 2009, Radiation research.

[3]  Huafeng Zhang,et al.  Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization , 2009, Proceedings of the National Academy of Sciences.

[4]  U. Mazurek,et al.  The hypoxic cell a target for selective cancer therapy , 2009 .

[5]  S. Kizaka-Kondoh,et al.  Significance of nitroimidazole compounds and hypoxia‐inducible factor‐1 for imaging tumor hypoxia , 2009, Cancer science.

[6]  Masahiro Hiraoka,et al.  The HIF-1-active microenvironment: an environmental target for cancer therapy. , 2009, Advanced drug delivery reviews.

[7]  M. Hiraoka,et al.  The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors* , 2009, Journal of Biological Chemistry.

[8]  M. Hiraoka,et al.  Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy , 2009, British Journal of Cancer.

[9]  G. Semenza,et al.  Regulation of cancer cell metabolism by hypoxia-inducible factor 1. , 2009, Seminars in cancer biology.

[10]  Mark W. Dewhirst,et al.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.

[11]  Richard P. Hill,et al.  Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[12]  Marianne Koritzinsky,et al.  Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. , 2008, Cancer research.

[13]  K. Kimura,et al.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.

[14]  M Hiraoka,et al.  Significance of HIF-1-active cells in angiogenesis and radioresistance , 2007, Oncogene.

[15]  M. Hiraoka,et al.  The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. , 2007, Biochemical and biophysical research communications.

[16]  M. Dewhirst,et al.  The potential role of intrinsic hypoxia markers as prognostic variables in cancer. , 2007, Antioxidants & redox signaling.

[17]  Michael Höckel,et al.  Detection and characterization of tumor hypoxia using pO2 histography. , 2007, Antioxidants & redox signaling.

[18]  R. Johnson,et al.  Hypoxia: A key regulator of angiogenesis in cancer , 2007, Cancer and Metastasis Reviews.

[19]  Charles H. Graham,et al.  Hypoxia-driven selection of the metastatic phenotype , 2007, Cancer and Metastasis Reviews.

[20]  Mark W. Dewhirst,et al.  Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment , 2007, Cancer and Metastasis Reviews.

[21]  Fang Li,et al.  Regulation of HIF-1α Stability through S-nitrosylation , 2007 .

[22]  M. Dewhirst.  Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. , 2007, Cancer research.

[23]  M. Dewhirst,et al.  Regulation of HIF-1alpha stability through S-nitrosylation. , 2007, Molecular cell.

[24]  A. Giaccia,et al.  Hypoxia, gene expression, and metastasis , 2007, Cancer and Metastasis Reviews.

[25]  V. Grégoire,et al.  Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.

[26]  M. Dewhirst,et al.  HIF-1 and tumour radiosensitivity , 2006, British Journal of Cancer.

[27]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[28]  E. Stanbridge,et al.  Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors. , 2005, Cancer research.

[29]  Masahiro Hiraoka,et al.  Optical Imaging of Tumor Hypoxia and Evaluation of Efficacy of a Hypoxia-Targeting Drug in Living Animals , 2005, Molecular imaging.

[30]  M. Ogura,et al.  Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts. , 2005, Journal of radiation research.

[31]  D. Demetrick,et al.  Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. , 2004, Carcinogenesis.

[32]  A. Giaccia,et al.  Hypoxic gene expression and metastasis , 2004, Cancer and Metastasis Reviews.

[33]  M. Dewhirst,et al.  Raising the Bar: How HIF-1 Helps Determine Tumor Radiosensitivity , 2004, Cell cycle.

[34]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[35]  M. Dewhirst,et al.  Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. , 2004, Cancer cell.

[36]  M. Hiraoka,et al.  Tumor hypoxia: A target for selective cancer therapy , 2003, Cancer science.

[37]  Jinho Kim,et al.  YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. , 2003, Journal of the National Cancer Institute.

[38]  Johan Bussink,et al.  Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  J. Pouysségur,et al.  Hypoxia‐inducible factor‐1α (HIF‐1α) escapes O2‐driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm , 2001 .

[40]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[41]  Chi V. Dang,et al.  Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression* , 2001, The Journal of Biological Chemistry.

[42]  J. Pouysségur,et al.  Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. , 2001, EMBO reports.

[43]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[44]  P Chambon,et al.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. , 1999, Nucleic acids research.

[45]  P Chambon,et al.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. , 1997, Biochemical and biophysical research communications.

[46]  M. Varia,et al.  Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. , 1997, International journal of radiation oncology, biology, physics.

[47]  M. Dewhirst,et al.  Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.

[48]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[49]  Y. Shibamoto,et al.  Reoxygenation after single irradiation in rodent tumors of different types and sizes. , 1996, International journal of radiation oncology, biology, physics.

[50]  P. Chambon,et al.  Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[53]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[54]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[55]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[56]  H. Kay.  Nucleus Cytoplasm , 1974 .

[57]  L. H. Gray,et al.  Influence of oxygen tension on x-ray-induced chromosomal damage in Ehrlich ascites tumor cells irradiated in vitro and in vivo. , 1959, Radiation research.

[58]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[59]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.